User menu

CYP3A4*22 and CYP3A combined genotypes both correlate with tacrolimus disposition in pediatric heart transplant recipients

Bibliographic reference Gijsen, Violette Mgj ; Van Schaik, Ron Hn ; Elens, Laure ; Soldin, Offie P ; Soldin, Steven J ; et. al. CYP3A4*22 and CYP3A combined genotypes both correlate with tacrolimus disposition in pediatric heart transplant recipients. In: Pharmacogenomics, Vol. 14, no. 9, p. 1027-1036 (2013)
Permanent URL
  1. Urbschat Anja, Obermüller Nicholas, Haferkamp Axel, Biomarkers of kidney injury, 10.3109/1354750x.2011.587129
  2. MallucheH, Sawaya BP, Hakim RM, Sayegh MH.Clinical Nephrology, Dialysis and Transplantation.Dustri-Verlag, FL, USA (2004).
  3. Kearns Gregory L., Abdel-Rahman Susan M., Alander Sarah W., Blowey Douglas L., Leeder J. Steven, Kauffman Ralph E., Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children, 10.1056/nejmra035092
  4. Blake Michael J., Castro Lisa, Leeder J. Steven, Kearns Gregory L., Ontogeny of drug metabolizing enzymes in the neonate, 10.1016/j.siny.2004.11.001
  5. Leeder J Steven, Developmental and pediatric pharmacogenomics, 10.1517/phgs.4.3.331.22693
  6. Rodriguez Santiago, Gaunt Tom R., Day Ian N. M., Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies, 10.1093/aje/kwn359
  7. Hesselink D, Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus, 10.1016/s0009-9236(03)00168-1
  8. van Schaik, Clin. Chem., 48, 1668 (2002)
  9. Volosov Andrew, Napoli Kimberly L., Soldin Steven J., Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography—tandem mass-spectrometry, 10.1016/s0009-9120(01)00235-1
  10. Schwartz George J., Brion Luc P., Spitzer Adrian, The Use of Plasma Creatinine Concentration for Estimating Glomerular Filtration Rate in Infants, Children, and Adolescents, 10.1016/s0031-3955(16)36251-4
  11. Stewart Susan, Winters Gayle L., Fishbein Michael C., Tazelaar Henry D., Kobashigawa Jon, Abrams Jacki, Andersen Claus B., Angelini Annalisa, Berry Gerald J., Burke Margaret M., Demetris Anthony J., Hammond Elizabeth, Itescu Silviu, Marboe Charles C., McManus Bruce, Reed Elaine F., Reinsmoen Nancy L., Rodriguez E. Rene, Rose Alan G., Rose Marlene, Suciu-Focia Nicole, Zeevi Adriana, Billingham Margaret E., Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart Rejection, 10.1016/j.healun.2005.03.019
  12. Elens L., Bouamar R., Hesselink D. A., Haufroid V., van der Heiden I. P., van Gelder T., van Schaik R. H. N., A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant Recipients, 10.1373/clinchem.2011.165613
  13. Elens Laure, van Schaik Ron H, Panin Nadtha, de Meyer Martine, Wallemacq Pierre, Lison Dominique, Mourad Michel, Haufroid Vincent, Effect of a new functionalCYP3A4polymorphism on calcineurin inhibitors’ dose requirements and trough blood levels in stable renal transplant patients, 10.2217/pgs.11.90
  14. Wang D, Guo Y, Wrighton S A, Cooke G E, Sadee W, Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs, 10.1038/tpj.2010.28
  16. Westlind Anna, Löfberg Lena, Tindberg Niclas, Andersson Tommy B., Ingelman-Sundberg Magnus, Interindividual Differences in Hepatic Expression of CYP3A4: Relationship to Genetic Polymorphism in the 5′-Upstream Regulatory Region, 10.1006/bbrc.1999.0752
  17. Shimada, J. Pharmacol. Exp. Ther., 270, 414 (1994)
  18. Lamba Jatinder K, Lin Yvonne S, Schuetz Erin G, Thummel Kenneth E, Genetic contribution to variable human CYP3A-mediated metabolism, 10.1016/s0169-409x(02)00066-2
  19. P.B. Danielson Bentham Science Publisher, The Cytochrome P450 Superfamily: Biochemistry, Evolution and Drug Metabolism in Humans, 10.2174/1389200023337054
  20. Gijsen Violette, Mital Seema, van Schaik Ron H., Soldin Offie P., Soldin Steven J., van der Heiden Ilse P., Nulman Irena, Koren Gideon, de Wildt Saskia N., Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients, 10.1016/j.healun.2011.08.001
  21. Zheng HongXia, Webber Steven, Zeevi Adriana, Schuetz Erin, Zhang Jiong, Bowman Pamela, Boyle Gerard, Law Yuk, Miller Susan, Lamba Jatinder, Burckart Gilbert J., Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms, 10.1034/j.1600-6143.2003.00077.x
  22. Kniepeiss Daniela, Renner Wilfried, Trummer Olivia, Wagner Doris, Wasler Andrä, Khoschsorur Gholam A., Truschnig-Wilders Martie, Tscheliessnigg Karl-Heinz, The role of CYP3A5 genotypes in dose requirements of tacrolimus and everolimus after heart transplantation : CYP3A5 and dosing of tacrolimus and everolimus, 10.1111/j.1399-0012.2009.01198.x
  23. Staatz Christine E., Goodman Lucy K., Tett Susan E., Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I : , 10.2165/11317350-000000000-00000
  24. Aidong W., Zhenjie C., Tong L., Lei Z., Yin W., Shanqi Z., Liping T., Therapeutic drug monitoring of tacrolimus in early stage after heart transplantation, 10.1016/j.transproceed.2004.06.037
  25. Robinson Blair V, Boyle Gerard J, Miller Susan A, Law Yuk M, Myers John L, Griffith Bartley P, Webber Steven A, Optimal dosing of intravenous tacrolimus following pediatric heart transplantation, 10.1016/s1053-2498(99)00036-4
  26. Penninga Luit, Møller Christian H., Gustafsson Finn, Steinbrüchel Daniel A., Gluud Christian, Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials, 10.1007/s00228-010-0902-6